News
LBCL: Bispecific Antibodies Fare Less Well in Real-World Analysis
- Author:
- Randy Dotinga
Publish date: December 9, 2024
News
ASH 2024: New Leukemia Txs, Fewer Blood Clots With GLP-1 Rxs
- Author:
- Randy Dotinga
Publish date: December 9, 2024
News
National Noncompete Ban Unlikely to Survive Under Trump, Experts Say
- Author:
- Randy Dotinga
Publish date: December 5, 2024
News
Blood Buddies: Can Mentorship Revive Classical Hematology?
- Author:
- Randy Dotinga
Publish date: November 26, 2024
News
Pharmacist Advocates for Early Adoption of Quadruple Therapy in HFrEF Treatment
- Author:
- Randy Dotinga
Publish date: November 25, 2024
News
Contraceptive Care Clinic Focuses on Military Readiness
- Author:
- Randy Dotinga
Publish date: November 19, 2024
News
From Mexico City to the Heights of Leukemia Medicine
- Author:
- Randy Dotinga
Publish date: November 15, 2024
Article
Rising Cancer Rates Among Young People Spur New Fertility Preservation Options
- Author:
- Randy Dotinga
Publish date: November 15, 2024
News
Registered Dieticians Sparse in VA Cancer Care
- Author:
- Randy Dotinga
Publish date: November 11, 2024
News
Myasthenia Gravis: Where Does Traditional Therapy Fit In?
- Author:
- Randy Dotinga
Publish date: November 6, 2024
News
New Drug Options Abound for Duchenne Muscular Dystrophy
- Author:
- Randy Dotinga
Publish date: November 6, 2024
News
Outpatient CAR T: Safe, Effective, Accessible
- Author:
- Randy Dotinga
Publish date: November 4, 2024
News
Cybersecurity Concerns Continue to Rise With Ransom, Data Manipulation, AI Risks
- Author:
- Randy Dotinga
Publish date: October 29, 2024
News
For Radiation ‘Downwinders,’ Cancer Compensation Is On Hold
- Author:
- Randy Dotinga
Publish date: October 25, 2024
News
Pediatric Myasthenia Gravis: Don’t Treat Children Like Adults
- Author:
- Randy Dotinga
Publish date: October 22, 2024